-
Bufalin Targets STK33 in Triple-Negative Breast Cancer
2026-08-19
A 2025 Advanced Science study identifies serine/threonine kinase 33 (STK33) as a binding target and degradation-sensitive vulnerability of Bufalin in triple-negative breast cancer. By combining chemoproteomic target discovery, biophysical binding assays, genetic perturbation, animal models, and patient-derived organoids, the work connects STK33 destabilization to suppression of tumor growth and metastasis.
-
GS967: Probing Late INa in Cardiac Aging
2026-08-19
GS967 is a cardiac late sodium current inhibitor for dissecting how persistent Nav1.5 activity links repolarization, calcium handling, and diastolic dysfunction. This article presents a mechanistic assay framework that connects pharmacological inhibition with aging and Ser571-dependent cardiac models.
-
Structure–Activity Insights into ω-Agatoxin IVA
2026-08-18
The reference study shows that ω-agatoxin IVA retains its inhibitor cystine knot in a membrane-mimetic environment while undergoing major conformational changes in its C-terminal tail and selected loops. NMR, membrane-partitioning analyses, and whole-cell patch-clamp experiments identify the hydrophobic C-terminal tail and a central Arg-rich region as key determinants of Cav2.1 blockade.
-
CX-5461: From Pol I Stress to Assay Design
2026-08-18
CX-5461 is an RNA polymerase I inhibitor that connects ribosome-biogenesis stress with DNA damage, mitotic catastrophe, autophagy, and senescence. This guide translates those distinct biological outcomes into a practical assay strategy for cancer research and combination studies.
-
10074-G5: Practical c-Myc Inhibitor Workflows
2026-08-17
10074-G5 enables mechanism-focused cancer research by separating c-Myc/Max dimerization effects from downstream apoptosis, cell cycle, and migration phenotypes. This guide translates the MYC/TERT/NFκB findings in esophageal adenocarcinoma into practical assay designs, dose-selection strategies, and troubleshooting steps.
-
DAPI Nuclear Stain Solution: Practical Guide
2026-08-16
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution, SKU K2402, provides a pre-diluted nuclear visualization dye for fixed or membrane-compromised cells in fluorescence microscopy and flow cytometry. Its weak cell permeability limits use in live-cell imaging, and DAPI positivity should not be interpreted as proof of apoptosis without additional controls.
-
ZNF263–STAT3 Signaling in Colorectal Cancer
2026-08-15
A Scientific Reports study identifies ZNF263 as an oncogenic regulator of colorectal cancer progression and chemoradiotherapy resistance, linking its activity to direct transcriptional control of STAT3. The work provides a mechanistic framework for interpreting ZNF263–STAT3 signaling in tumor invasion, epithelial–mesenchymal transition, and therapy-response research.
-
5-Aminolevulinic Acid HCl in Heme Flux Studies
2026-08-15
5-Aminolevulinic acid HCl offers a strategic way to interrogate heme-pathway flux rather than merely measure endpoint abundance. This article connects the reagent’s biochemical role with Salmonella–macrophage assay design, highlighting controls, interpretation limits, and translational relevance.
-
HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody
2026-08-14
Map goat-primary signals across viral replication-organelle imaging, Western blotting, flow cytometry, and tissue staining with a bright Alexa Fluor 488 conjugated secondary antibody. Its affinity purification and H+L-chain recognition support sensitive, adaptable workflows for studying FXR condensates and β-coronavirus-induced membrane remodeling.
-
Proteinase K for DNA Workflows and Fungal EV Research
2026-08-14
Proteinase K combines broad protein hydrolysis with compatibility across DNA isolation conditions, making it useful for genomic DNA cleanup, nuclease removal, and controlled extracellular-vesicle assays. This guide connects practical Proteinase K workflows with recent Candida albicans EV findings while separating validated product performance from recommended experimental extensions.
-
Vitamin C in Organoid Assay Design
2026-08-13
Explore how Vitamin C and ascorbic acid can be evaluated with decision-focused organoid assays spanning cancer research and HEV models. This guide separates established anticancer evidence from emerging antiviral hypotheses and provides practical parameters for reproducible experiments.
-
Thiothixene for Macrophage Efferocytosis
2026-08-13
Thiothixene is a typical antipsychotic agent with a distinctive research use beyond dopamine receptor pharmacology: enhancing macrophage clearance of apoptotic and lipid-laden cells. This guide translates its Stra6l–vitamin A–Arginase 1 biology into practical in vitro workflows while separating assay evidence from schizophrenia treatment and drug-target discovery.
-
Optimizing hiPSC-Derived Platelet Production
2026-08-12
A 2026 study presents an optimized differentiation scheme that increases megakaryocyte and platelet output from human induced pluripotent stem cells while shortening production to 19 days. Its combination of higher embryoid-body input, human platelet lysate, small-molecule cytokine substitutes, and maturation enhancers improved yield, in vitro platelet function, and cost efficiency.
-
lncRNA HITT, ATM Activation, and Cancer Sensitization
2026-08-12
The reference study identifies lncRNA HITT as an endogenous brake on ATM activation after DNA double-strand breaks. By binding the ATM HEAT-repeat domain and limiting MRN-dependent recruitment, HITT weakens homologous recombination repair and increases cancer-cell sensitivity to genotoxic treatment.
-
NSC 87877: Shp2 Inhibitor Workflow
2026-08-11
NSC 87877 gives researchers a chemical route to test whether Shp2 activity connects microglial signaling with NLRP3-driven inflammation after ischemic injury. This practical guide combines assay setup, pathway controls, handling advice, and translational comparisons for neuroinflammation, leukemia, and pain studies.
444 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page